3 terminated, 1 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 3, Completed 1 |
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow PRTX-100: new trials by email Literature Review of PRTX-100 trials Research Report on PRTX-100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP PRTX-100 - Immune Thrombocytopenia | Phase 1 / Phase 2 | Terminated | Protalex, Inc. | 15 | 2015-11-01 | 2019-03-25 |
| PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP PRTX-100 - Immune Thrombocytopenia | Phase 1 / Phase 2 | Terminated | Protalex, Inc. | 13 | 2015-09-01 | 2019-07-05 |
| 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection PRTX-100 - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Completed | Protalex, Inc. | 13 | 2015-02-01 | 2018-10-16 |
| Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP PRTX-100 (Staphylococcal protein A) - Idiopathic Thrombocytopenic Purpura (ITP) | Phase 1 | Terminated | Protalex, Inc. | 9 | 2007-12-01 | 2018-07-20 |
Purpura, Thrombocytopenic, Idiopathic (3) · Thrombocytopenia (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Hematologic Diseases (1) · Hemostatic Disorders (1)
Protalex, Inc. (4)
United Kingdom (2) · United States (2) · Australia (1) · France (1) · New Zealand (1)
Edward Bernton, MD (1) · John B McClain, MD (1) · William E Gannon Jr., MD (1) · William E Gannon, MD (1)
2014 (1)